Glenmark Pharmaceuticals Limited — Others, 29-04-2025: News Verification

Glenmark Pharmaceuticals has clarified that spurious products, including certain drug batches mentioned in media reports, were not produced by the company or its affiliates. Regulatory authorities, including COSCO and the West Bengal Department of Health, have officially classified these products as counterfeit. Glenmark is actively addressing counterfeit concerns by improving packaging and supply chain integrity. This clarification is significant as it safeguards Glenmark's reputation and reassures stakeholders regarding the integrity and safety of its products.